myriad genetics stock analysis

6 2020 at 636 am. Discover the Power of thinkorswim Today.


Mygn Myriad Genetics Stock Price

Comparatively Myriad Genetics has a beta of 17 indicating that its stock.

. Ad Start your 3-week trial and begin picking the right stocks today. Find the latest analyst research for Myriad Genetics Inc. Is a genetic testing and precision medicine company.

The summary of MYRIAD GENETICS. Share on Twitter Share on Facebook Share on. VolitionRx has lower revenue but higher earnings than Myriad Genetics.

Myriad Genetics Inc Stock Analysis - NASDAQMYGN TradingView. The Company primarily provides testing and collaborative development of testing that is designed. Myriad Genetics Inc.

Markets US Stocks Health Technology. Myriad Genetics stock price target cut to 14 from 17 at JP. This gauge displays a real-time technical analysis overview for your selected timeframe.

MYGN Myriad Genetics - Stock quote performance technical chart analysis SmartSelect Ratings Group Leaders and the latest company headlines. Myriad Genetics stock price up 098 on MondayUpdated on Aug 15 2022 Buy or Hold candidate since 2022-07-11 Gain 4371 PDF. Ad Myriad Genetics MyRisk Hereditary Cancer Test helps you understand your own cancer risk.

Posted by MarketBeat News on Aug 17th 2022. VolitionRx has a beta of 162 indicating that its stock price is 62 more volatile than the SP 500. See more on advanced chart.

Make more informed healthcare choices with Myriads hereditary cancer testing products. Myriad Genetics MYGN - DEVELOPS. MYGN stock analysis from Seeking Alphas top analysts.

Your technical analysis summary for MYRIAD GENETICS INC. Ad Myriad Genetics MyRisk Hereditary Cancer Test helps you understand your own cancer risk. The new indifference towards the small price fluctuations of MYRIAD GENETICS INC could raise concerns from stakeholders as the firm is trading at a share price of 00 on very low.

The Myriad Genetics stock price gained. Find the latest Myriad Genetics Inc. See Myriad Genetics Inc.

Track Screen Pick Winning Stocks Faster Beat the Market More Often Demo it Today. The stock has a market capitalization of 225 billion a price-to-earnings ratio of -11616 and a. VolitionRx NYSEVNRX and Myriad Genetics NASDAQMYGN Critical Contrast.

Exclusive research and insights from bulls and bears. Real time Myriad Genetics MYGN stock price quote stock graph news analysis. ET by Tomi Kilgore Health Myriad Genetics Stock Is Tanking After Earnings.

Myriad Genetics is trading at a lower price-to-earnings ratio. Make more informed healthcare choices with Myriads hereditary cancer testing products. Myriad Genetics Stock Performance MYGN stock opened at 2788 on Tuesday.

MYGN stock analyst estimates including earnings and revenue EPS upgrades and downgrades. Myriad Genetics Stock analysis including Myriad Genetics investment evaluation stock information alerts predictive tools such as market volatility and liquidity estimators and more.


Myriad Genetics Inc Nasdaq Mygn Insiders Miss Last Week S 3 6 Gain After Selling Stock Over The Past Year Mtech News


Myriad Genetics Inc 2022 Q1 Results Earnings Call Presentation Nasdaq Mygn Seeking Alpha


Mygn Stock Price And Chart Nasdaq Mygn Tradingview


Monitoring Myriad Genetics Nasdaq Mygn Seeking Alpha


Mygn Stock Price And Chart Nasdaq Mygn Tradingview


Reasons To Hold On To Myriad Genetics Mygn Stock For Now


Here S Why You Should Retain Myriad Genetics Mygn Stock Now


Reasons To Hold On To Myriad Genetics Mygn Stock For Now Nasdaq


Mygn Stock Price And Chart Nasdaq Mygn Tradingview


Leadership In Hereditary Cancer Testing Will Drive Myriad Genetics Stock In 2018 Nasdaq Mygn Seeking Alpha


Mygn Stock Price And Chart Nasdaq Mygn Tradingview


Technical Analysis Of Myriad Genetics Inc Nasdaq Mygn Stock Chartmill Com


Monitoring Myriad Genetics Nasdaq Mygn Seeking Alpha


Mygn Stock Price And Chart Nasdaq Mygn Tradingview


Myriad Genetics Inc Mygn Stock Price News Google Finance


Mygn Stock Price And Chart Nasdaq Mygn Tradingview


Myriad Genetics Inc Shares Fall 2 1 Below Previous 52 Week Low Market Mover Nasdaq


Myriad Genetics Mygn Q3 Loss Wider Than Expected Revenues Top


Myriad Genetics Mygn Reports Loss In Q1 Gross Margin Down

Iklan Atas Artikel

Iklan Tengah Artikel 1

Iklan Tengah Artikel 2

Iklan Bawah Artikel